Industry Growth Insights published a new data on “Circulating Tumor Cells (CTC) Market”. The research report is titled “Circulating Tumor Cells (CTC) Market research by Types (Ex-Vivo Positive Selection, In-Vivo Positive Selection, Negative Selection, Microchips & Single Spiral Micro Channel), By Applications (Tumorigenesis Research, Emt Biomarkers Development, Cancer Stem Cell Research, Others), By Players/Companies AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech, Nanostring Technologies, Rarecells Diagnostics, Vitatex”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Circulating Tumor Cells (CTC) Market Research Report
By Type
Ex-Vivo Positive Selection, In-Vivo Positive Selection, Negative Selection, Microchips & Single Spiral Micro Channel
By Application
Tumorigenesis Research, Emt Biomarkers Development, Cancer Stem Cell Research, Others
By Companies
AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech, Nanostring Technologies, Rarecells Diagnostics, Vitatex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Circulating Tumor Cells (CTC) Market Report Segments:
The global Circulating Tumor Cells (CTC) market is segmented on the basis of:
Types
Ex-Vivo Positive Selection, In-Vivo Positive Selection, Negative Selection, Microchips & Single Spiral Micro Channel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumorigenesis Research, Emt Biomarkers Development, Cancer Stem Cell Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AdnaGen
- Apocell
- Biocep
- Canopus Bioscience
- Creatv Microtech
- Ikonisys
- IV Diagnostics
- Miltenyi Biotech
- Nanostring Technologies
- Rarecells Diagnostics
- Vitatex
Highlights of The Circulating Tumor Cells (CTC) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ex-Vivo Positive Selection
- In-Vivo Positive Selection
- Negative Selection
- Microchips & Single Spiral Micro Channel
- By Application:
- Tumorigenesis Research
- Emt Biomarkers Development
- Cancer Stem Cell Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Circulating Tumor Cells (CTC) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Circulating tumor cells (CTC) are cancerous cells that have spread from the original site of the tumor to other parts of the body. CTCs can be detected by a blood test and may help doctors determine if a patient has cancer.
Some of the major companies in the circulating tumor cells (ctc) market are AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech, Nanostring Technologies, Rarecells Diagnostics, Vitatex.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Circulating Tumor Cells (CTC) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Circulating Tumor Cells (CTC) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Circulating Tumor Cells (CTC) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Circulating Tumor Cells (CTC) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Circulating Tumor Cells (CTC) Market Size & Forecast, 2020-2028 4.5.1 Circulating Tumor Cells (CTC) Market Size and Y-o-Y Growth 4.5.2 Circulating Tumor Cells (CTC) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Ex-Vivo Positive Selection
5.2.2 In-Vivo Positive Selection
5.2.3 Negative Selection
5.2.4 Microchips & Single Spiral Micro Channel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tumorigenesis Research
6.2.2 Emt Biomarkers Development
6.2.3 Cancer Stem Cell Research
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Circulating Tumor Cells (CTC) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Circulating Tumor Cells (CTC) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Ex-Vivo Positive Selection
9.6.2 In-Vivo Positive Selection
9.6.3 Negative Selection
9.6.4 Microchips & Single Spiral Micro Channel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tumorigenesis Research
9.10.2 Emt Biomarkers Development
9.10.3 Cancer Stem Cell Research
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Ex-Vivo Positive Selection
10.6.2 In-Vivo Positive Selection
10.6.3 Negative Selection
10.6.4 Microchips & Single Spiral Micro Channel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tumorigenesis Research
10.10.2 Emt Biomarkers Development
10.10.3 Cancer Stem Cell Research
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Ex-Vivo Positive Selection
11.6.2 In-Vivo Positive Selection
11.6.3 Negative Selection
11.6.4 Microchips & Single Spiral Micro Channel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tumorigenesis Research
11.10.2 Emt Biomarkers Development
11.10.3 Cancer Stem Cell Research
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Ex-Vivo Positive Selection
12.6.2 In-Vivo Positive Selection
12.6.3 Negative Selection
12.6.4 Microchips & Single Spiral Micro Channel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tumorigenesis Research
12.10.2 Emt Biomarkers Development
12.10.3 Cancer Stem Cell Research
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Ex-Vivo Positive Selection
13.6.2 In-Vivo Positive Selection
13.6.3 Negative Selection
13.6.4 Microchips & Single Spiral Micro Channel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tumorigenesis Research
13.10.2 Emt Biomarkers Development
13.10.3 Cancer Stem Cell Research
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Circulating Tumor Cells (CTC) Market: Competitive Dashboard
14.2 Global Circulating Tumor Cells (CTC) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AdnaGen
14.3.2 Apocell
14.3.3 Biocep
14.3.4 Canopus Bioscience
14.3.5 Creatv Microtech
14.3.6 Ikonisys
14.3.7 IV Diagnostics
14.3.8 Miltenyi Biotech
14.3.9 Nanostring Technologies
14.3.10 Rarecells Diagnostics
14.3.11 Vitatex